VR Visual Field testing with Abdullah Sarhan, ep 39

/ West Coast Glaucoma/
VR Visual Field testing with Abdullah Sarhan, ep 39

In this episode, I talk with Abdullah “Abbott” Sahran, CEO and Co-founder of Retinal Logic, about the company's use of AR and VR technology for vision screening. Abbott shares his background in deep learning and healthcare, the development of the virtual reality prototype, the device's availability and Health Canada approval, and its differentiation from other companies' technologies. He also discusses the various test sizes and algorithms available, ongoing research, user experience, and the company's future roadmap.

Read More

Ep 34 Talking About Glaucoma - 7May2021 LAROCHE Daniel Cost effective Suprachoroidal Shunt (AAC)

/ Dr. Robert Schertzer Inc. / West Coast Glaucoma/
Ep 34 Talking About Glaucoma - 7May2021 LAROCHE Daniel Cost effective Suprachoroidal Shunt (AAC)

In this episode, I talk with Daniel Laroche. We have crossed paths for many years at conferences having both started our practices at the same time, but this was the first time we sat down to record our conversation. Daniel Laroche is Director of Glaucoma Services and President of Advanced Eyecare of New York. He is affiliated with the New York Eye and Ear Infirmary, and Assistant Professor of Ophthalmology at the Mount Sinai School of Medicine, New York.

Read More

Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

/ Dr Robert Schertzer Inc/
Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of research, Aerie Pharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals…and we’re Talking About Glaucoma.

Read More